{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T17:49:31Z","timestamp":1792259371257,"version":"4.4.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Neurosurgery"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.wneu.2023.08.018","type":"journal-article","created":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T23:37:40Z","timestamp":1691797060000},"page":"118-126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Central Nervous System Lymphoproliferative Disorder Secondary to Methotrexate: A Systematic Literature Review and Case Illustration"],"prefix":"10.1016","volume":"179","author":[{"given":"Alexander","family":"In","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2511-5931","authenticated-orcid":false,"given":"Brittany M.","family":"Stopa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua A.","family":"Cuoco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Stump","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa S.","family":"Apfel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cara M.","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.wneu.2023.08.018_bib1","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000019850","article-title":"Methotrexate-associated lymphoproliferative disorders in the central nervous system and stomach: a case report","volume":"99","author":"Kawazoe","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.wneu.2023.08.018_bib2","series-title":"WHO Classification of Tumors of the Haematopoietics and Lymphoid Tissues","first-page":"462","article-title":"Other iatrogenic immunodeficiency-associated lymphoproliferative disorders","author":"Gaulard","year":"2017"},{"key":"10.1016\/j.wneu.2023.08.018_bib3","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2176\/nmccrj.cr.2019-0241","article-title":"Primary central nervous system methotrexate-associated lymphoproliferative disorder in a patient with rheumatoid arthritis: case report and review of literature","volume":"7","author":"Uneda","year":"2020","journal-title":"NMC Case Rep J"},{"key":"10.1016\/j.wneu.2023.08.018_bib4","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1093\/neuonc\/nov297","article-title":"American brain tumor association adolescent and young adult primary brain and central nervous system tumors diagnosed in the United States in 2008-2012","volume":"18","author":"Ostrom","year":"2016","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.wneu.2023.08.018_bib5","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1309\/N82CTQ1J0XEVEFQB","article-title":"Primary central nervous system posttransplant lymphoproliferative disorders","volume":"121","author":"Castellano-Sanchez","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.wneu.2023.08.018_bib6","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3960\/jslrt.19028","article-title":"Immune response in LPD during methotrexate administration (MTX-LPD) in rheumatoid arthritis patients","volume":"59","author":"Saito","year":"2019","journal-title":"J\u00a0Clin Exp Hematop"},{"key":"10.1016\/j.wneu.2023.08.018_bib7","doi-asserted-by":"crossref","first-page":"e136","DOI":"10.1038\/emm.2014.102","article-title":"Epstein barr virus-associated lymphoproliferative diseases: the virus as a therapeutic target","volume":"47","author":"Tse","year":"2015","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.wneu.2023.08.018_bib8","first-page":"322","article-title":"Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication","volume":"34","author":"Hoshida","year":"2007","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.wneu.2023.08.018_bib9","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1136\/annrheumdis-2016-eular.3770","article-title":"AB0294 Lymphocyte recovery after methotrexate discontinuation relate to spontaneous regression of MTX-LPD in RA patients","volume":"75","author":"Kameda","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.wneu.2023.08.018_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/v14010115","article-title":"New evidence of significant association between EBV presence and lymphoproliferative disorders susceptability in patients with rheumatoid arthritis: a systematic review with meta-analysis","volume":"14","author":"Banko","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.wneu.2023.08.018_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.650713","article-title":"Altered antibody response to epstein-barr virus in patients with rheumatoid arthritis and healthy subjects predisposed to the disease. A twin study","volume":"12","author":"Svendsen","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.wneu.2023.08.018_bib12","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V99.11.3909","article-title":"Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France","volume":"99","author":"Mariette","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.wneu.2023.08.018_bib13","article-title":"Methotrexate-associated lymphoproliferative disorder with hypopituitarism and central diabetes insipidus","volume":"2019","author":"Aoshima","year":"2019","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"10.1016\/j.wneu.2023.08.018_bib14","article-title":"Methotrexate-associated primary hepatic lymphoma and cranial neuropathy in a patient with rheumatoid arthritis: a case report with clinical follow-up over a 7-year period","volume":"98","author":"Park","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.wneu.2023.08.018_bib15","doi-asserted-by":"crossref","first-page":"832","DOI":"10.3109\/s10165-012-0717-7","article-title":"Epstein-Barr virus and methotrexate-related CNS lymphoma in a patient with rheumatoid arthritis","volume":"23","author":"Migita","year":"2013","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.wneu.2023.08.018_bib16","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/1097-0142(197410)34:4<1293::AID-CNCR2820340441>3.0.CO;2-P","article-title":"Primary malignant lymphomas of the central nervous system","volume":"34","author":"Henry","year":"1974","journal-title":"Cancer"},{"key":"10.1016\/j.wneu.2023.08.018_bib17","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1212\/WNL.40.1.80","article-title":"Primary CNS lymphoma: combined treatmnet with chemotherapy and radiotherapy","volume":"40","author":"DeAngelis","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.wneu.2023.08.018_bib18","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.wneu.2023.08.018_bib19","doi-asserted-by":"crossref","first-page":"677","DOI":"10.7326\/M19-0891","article-title":"The accuracy of google translate for abstracting data from non-English-language trials for systematic reviews","volume":"171","author":"Jackson","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.wneu.2023.08.018_bib29","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13104-015-1040-0","article-title":"Primary central nervous system lymphoma in a rheumatoid arthritis patient treated with methotrexate: a case report","volume":"8","author":"Shimada","year":"2015","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.wneu.2023.08.018_bib21","doi-asserted-by":"crossref","first-page":"824","DOI":"10.3109\/02688697.2013.798857","article-title":"Primary central nervous system malignant lymphoma in a patient with rheumatoid arthritis receiving low-dose methotrexate treatment","volume":"27","author":"Fukushima","year":"2013","journal-title":"Br J Neurosurg"},{"key":"10.1016\/j.wneu.2023.08.018_bib26","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.wneu.2019.06.226","article-title":"Intracranial methotrexate-associated lymphoproliferative disorder in rheumatoid arthritis","volume":"130","author":"Miyaza","year":"2019","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wneu.2023.08.018_bib24","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1212\/01.wnl.0000334757.16882.37","article-title":"Polyradiculopathy due to methotrexate-induced EBV-associated lymphoproliferative disorder","volume":"71","author":"Kumar","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.wneu.2023.08.018_bib23","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1097\/NEN.0b013e31818beaea","article-title":"Epstein Barr Virus-associated primary CNS lymphomas in elderly patients on immunosuppressive medications","volume":"67","author":"Kleinschmidt-DeMasters","year":"2008","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"key":"10.1016\/j.wneu.2023.08.018_bib25","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/bjh.14978","article-title":"Methotrexate-associated lymphoproliferative disorder masquerading as multiple cerebral metastases","volume":"180","author":"Matsuda","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.wneu.2023.08.018_bib20","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3143\/geriatrics.59.96","article-title":"[A case of methotrexate-associated diffuse large B-cell lymphoma with splenial lesions of the corpus callosum on brain MRI after complete remission with chemotherapy]","volume":"59","author":"Aoki","year":"2022","journal-title":"Nihon Ronen Igakkai Zasshi"},{"key":"10.1016\/j.wneu.2023.08.018_bib28","first-page":"13","article-title":"Intracerebral manifestation of iatrogenic, immunodeficiency-associated polymorphic B-LPD with morphology mimicking hodgkin lymphoma: a case report and literature review","volume":"15","author":"Saft","year":"2022","journal-title":"J\u00a0Hematop"},{"key":"10.1016\/j.wneu.2023.08.018_bib22","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2176\/nmccrj.cr.2020-0234","article-title":"Primary central nervous system T-cell lymphoma as methotrexate-associated lymphoproliferative disorders: case report","volume":"8","author":"Kawano","year":"2021","journal-title":"NMC Case Rep J"},{"key":"10.1016\/j.wneu.2023.08.018_bib27","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/RLU.0b013e318162db78","article-title":"Methotrexate-induced and epstein-barr virus-associated B-cell lymphoma of the spine: MR and PET\/CT imaging","volume":"33","author":"Nguyen","year":"2008","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.wneu.2023.08.018_bib30","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2169\/internalmedicine.54.2399","article-title":"Primary cerebral lymphomatoid granulomatosis progressing to methotrexate-associated lymphoproliferative disease under immunosuppressive therapy","volume":"54","author":"Tanaka","year":"2015","journal-title":"Intern Med"},{"key":"10.1016\/j.wneu.2023.08.018_bib31","doi-asserted-by":"crossref","first-page":"485","DOI":"10.5692\/clinicalneurol.cn-001157","article-title":"[Primary central nervous system methotrexate associated lymphoproliferative disorders in a patietn with rheumatoid arthritis]","volume":"58","author":"Uchida","year":"2018","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.wneu.2023.08.018_bib32","author":"Kane"},{"key":"10.1016\/j.wneu.2023.08.018_bib33","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1002\/acr.22306","article-title":"Association of higher methotrexate dose with lymphoproliferative disease onset in rheumatoid arthritis patients","volume":"66","author":"Kameda","year":"2014","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.wneu.2023.08.018_bib34","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2176\/jns-nmc.2022-0091","article-title":"Successful treatment of intracranial methotrexate-associated lymphoproliferative disorder without Epstein-Barr virus infection using rituximab, methotrexate, procarbazine, and vincristine: a case report","volume":"9","author":"Mizushima","year":"2022","journal-title":"NMC Case Rep J"},{"key":"10.1016\/j.wneu.2023.08.018_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2018.00211","article-title":"Epstein-Barr virus epidemiology, serology, and genetic variability of LMP-1 oncogene among healthy population: an update","volume":"8","author":"Smatti","year":"2018","journal-title":"Front Oncol"},{"key":"10.1016\/j.wneu.2023.08.018_bib36","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/ejh.12116","article-title":"Methotrexate\/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression","volume":"91","author":"Ichikawa","year":"2013","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.wneu.2023.08.018_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14397595.2017.1352477","article-title":"Lymphoproliferative disorders in patients with rheumatoid arthritis in the era of widespread use of methotrexate: a review of the literature and current perspective","volume":"28","author":"Harigari","year":"2018","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.wneu.2023.08.018_bib38","series-title":"Primary CNS Lymphoma Treatment (PDQ). PDQ Cancer Informaiton Summaries","year":"2022"},{"key":"10.1016\/j.wneu.2023.08.018_bib39","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1212\/WNL.0000000000000593","article-title":"High-dose methotrexate with or without rituximab in newly diagnosed primary CNS lymphoma","volume":"83","author":"Holdhoff","year":"2014","journal-title":"Neurology"}],"container-title":["World Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875023011208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875023011208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T09:24:46Z","timestamp":1761816286000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878875023011208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":39,"alternative-id":["S1878875023011208"],"URL":"https:\/\/doi.org\/10.1016\/j.wneu.2023.08.018","relation":{},"ISSN":["1878-8750"],"issn-type":[{"value":"1878-8750","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Central Nervous System Lymphoproliferative Disorder Secondary to Methotrexate: A Systematic Literature Review and Case Illustration","name":"articletitle","label":"Article Title"},{"value":"World Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.wneu.2023.08.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}